This year it is expected that over 54,000 people in the United States will be diagnosed with cancer of the liver or biliary system, while over 60,000 will be diagnosed with pancreatic cancer, and nearly 150,000 will be diagnosed with colorectal cancer,
according to the American Cancer Society. While many tumors are detected after workup of symptoms such as abdominal pain, rectal bleeding, or jaundice,
many others are found by accident when no symptoms are present. Early detection and comprehensive treatment planning is critical to optimizing both survival and quality of life.
The Gastrointestinal Cancer Program at Northside Hospital Cancer Institute brings together our leading experts in surgical, medical, and radiation oncology along with interventional radiology, pathology, radiology and genetic counseling. Providing the best possible outcomes for our patients. Our specialists treat all kinds of gastrointestinal and abdominal cancers, including tumors of the colon, rectum, pancreas, liver, bile duct, stomach, small intestine, mesentery, peritoneum and retroperitoneum.
As Georgia’s largest and most comprehensive cancer care provider, Northside Hospital Cancer Institute (NHCI) diagnoses and treats more new cases of colorectal cancer than any other community hospital in Georgia and is among the top programs in the
country. We provide colon and rectal cancer patients with access to interdisciplinary services with the most powerful combination of physician experts, facilities, and resources of any cancer program in Georgia.
Northside Hospital’s Liver & Pancreas Program is committed to providing safe and effective care to patients diagnosed with hepatobiliary, pancreatic, and rare or complex gastrointestinal cancers. Our physicians and surgeons are experts in the management of a broad range of abdominal tumors including, but not limited to:
The Gastrointestinal Cancer Program embraces the NHCI mission to provide compassionate, personalized patient care utilizing a multidisciplinary care team approach; practicing evidence-based medicine; and, providing cutting-edge treatments and technologies.